Cui, Xinyan Tracy
- University of Pittsburgh (no department on record)
- Vanish Therapeutics Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,052
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$939K
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#11,052
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Cui, Xinyan Tracy as a PI. Multi-PI records show the full award amount for context.
- 5R01NS110564-05R01Contact PIEfficiency and Safety of Microstimulation Via Different Electrode Materials$581.7Kaward amount
- 1R41NS132625-01A1R41Contact PIOpioid-Sparing Non-Surgical, Bioresorbable Nerve Stimulator for Pain Relief$347Kaward amount
- 3R01NS110564-05S1R01Contact PIEfficiency and Safety of Microstimulation Via Different Electrode Materials$10.4Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Cui, Xinyan Tracy as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardUniversity of Pittsburgh
- 2009$500K Cumulative Funding
- 2009Multi-Institutional ResearchAwards at 2 institutions
- 2010$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014R01 Grant Holder
- 2015Entered Top 50% NationallyRanked #5361
- 2017$5M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #4559
- 2021$10M Cumulative Funding